Caption Management, LLC Atossa Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$0.59 - $0.91 $44,250 - $68,250	75,000 New	75,000 $54,000
Q1 2022 May 13, 2022	SELL	$1.11 - $1.74 $333,000 - $522,000	-300,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.6 - $3.27 $293,280 - $599,391	183,300 Added 157.07%	300,000 $480,000
Q3 2021 Nov 12, 2021	SELL	$2.89 - $6.4 $952,255 - $2.11 Million	-329,500 Reduced 73.85%	116,700 $380,000
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $549,024 - $3.11 Million	361,200 Added 424.94%	446,200 $2.82 Million
Q1 2021 May 17, 2021	BUY	$0.92 - $4.33 $78,200 - $368,050	85,000 New	85,000 $179,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.